Reviva Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Reviva Pharmaceuticals's estimated annual revenue is currently $2.2M per year.
- Reviva Pharmaceuticals's estimated revenue per employee is $116,368
- Reviva Pharmaceuticals's total funding is $41.4M.
Employee Data
- Reviva Pharmaceuticals has 19 Employees.
- Reviva Pharmaceuticals grew their employee count by 6% last year.
Reviva Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | VP Quality | Reveal Email/Phone |
3 | Head CMC | Reveal Email/Phone |
4 | VP, Regulatory Affairs | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Director Clinical Trials Operations | Reveal Email/Phone |
7 | Quality Assurance Manager | Reveal Email/Phone |
8 | President and CEO | Reveal Email/Phone |
Reviva Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Reviva Pharmaceuticals?
Reviva is developing a portfolio of internally discovered next generation safe and effective therapeutic drugs. Our research programs are focused on the central nervous system (CNS), cardiovascular (CV), metabolic and inflammatory indications. We develop small molecule therapeutics using chemical genomics based technology platform and proprietary chemistries. Reviva's products are new chemical entities (NCEs), and are designed to be safe, highly potent, selective, and orally bioavailable for improved patient compliance. Our product candidates and their current status are summarized in the following chart.
keywords:N/A$41.4M
Total Funding
19
Number of Employees
$2.2M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Reviva Pharmaceuticals News
Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation...
Reviva Pharmaceuticals Holdings, Inc. (RVPH) is down 12.04% Thursday In Premarket Trading. Thursday, April 07, 2022 06:49 AM | InvestorsObserver Analysts.
Reviva is a clinical-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for...
CUPERTINO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascul ...
CUPERTINO, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.7M | 19 | 0% | N/A |
#2 | $1.7M | 19 | N/A | N/A |
#3 | $1.7M | 19 | 19% | N/A |
#4 | $1.7M | 19 | 0% | N/A |
#5 | $0.6M | 19 | -49% | $16M |